Stoke Therapeutics, Inc. · NASDAQ:STOK

FMR LLC reported a 10.70% stake in Stoke Therapeutics, Inc. (Schedule 13G)

Event May 30, 2025 · Filed Jun 6, 2025

FMR LLC reported a 10.70% stake in Stoke Therapeutics, Inc., 5,859,011 shares, as a passive investor on May 30, 2025. Filed Jun 6, 2025 (Schedule 13G).

Stake: 10.70%
Shares: 5,859,011
Intent: Passive
What changed: Crossed above 5%
Filed together: 2 holders

The filing in full

Holder	Stake	Shares
FMR LLC	10.70%	5,859,011
Abigail P. Johnson	10.70%	5,859,011

Source

View original at SEC

Related